Results 11 to 20 of about 18,603 (227)

Aptamers and Cancer

open access: yesAsian Pacific Journal of Cancer Biology, 2016
Oligonucleotides Aptamers are single strands of DNA and RNA with the length of 20-100 nucleotides or peptides and unique three dimensional structure that is affected by nucleotide sequence. The structure exclusively influences aptamers’ bindings with its target molecule.
Yazdanpanahi, Nasrin   +2 more
openaire   +5 more sources

The life marker chip : potential use of aptamers against small molecules and consideration of instrument planetary protection [PDF]

open access: yes, 2013
The Life Marker Chip (LMC) instrument was developed with the aim to detect evidence of life on Mars. The detection was based on an inhibition immunoassay. In this work aptamers were evaluated as potential alternative to antibodies for the LMC.
Rato, Carla Cristina Pereira Salgueiro Catarino
core   +7 more sources

Aptamers and Their Biological Applications [PDF]

open access: yesSensors, 2012
Recently, aptamers have attracted the attention of many scientists, because they not only have all of the advantages of antibodies, but also have unique merits, such as thermal stability, low cost, and unlimited applications.
Changill Ban   +2 more
doaj   +5 more sources

Preliminary in vivo characterization of a theranostic aptamer: Sgc8-c- DOTA-67Ga [PDF]

open access: yes, 2017
Nucleic acid aptamers can recognise their target with high affinity and specificity, and their potential as molecular imaging agents and use in theranostics are being explored.
Cerecetto, Hugo   +9 more
core   +7 more sources

Aptamers and aptamer targeted delivery [PDF]

open access: yesRNA Biology, 2009
When aptamers first emerged almost two decades ago, most were RNA species that bound and tagged or inhibited simple target ligands. Very soon after, the 'selectionologists' developing aptamer technology quickly realized more potential for the aptamer.
Amy C, Yan, Matthew, Levy
openaire   +2 more sources

Aptamer Database [PDF]

open access: yesNucleic Acids Research, 2004
The aptamer database is designed to contain comprehensive sequence information on aptamers and unnatural ribozymes that have been generated by in vitro selection methods. Such data are not normally collected in 'natural' sequence databases, such as GenBank.
Jennifer F. Lee   +3 more
openaire   +2 more sources

Aptamer Applications in Neuroscience [PDF]

open access: yesPharmaceuticals, 2021
Being the predominant cause of disability, neurological diseases have received much attention from the global health community. Over a billion people suffer from one of the following neurological disorders: dementia, epilepsy, stroke, migraine, meningitis, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis ...
Meric Ozturk   +2 more
openaire   +7 more sources

Aptamer and aptamer pharmaceuticals [PDF]

open access: yesSCIENTIA SINICA Chimica, 2018
Recently, molecule-based targeted therapy has achieved remarkable success in clinical, and opened up a new era particulraly in the field of cancer therapy. Monoclonal antibodies and small molecule inhibitors are two pillars of this field. Additionally, a single-strand nucleic acid molecule called “chemical antibody” has also attracted increasing ...
Ting Zheng, Ziyue Ma, Quan Du
openaire   +1 more source

Aptamer Bioinformatics [PDF]

open access: yesInternational Journal of Molecular Sciences, 2017
Aptamers are short nucleic acid sequences capable of specific, high-affinity molecular binding. They are isolated via SELEX (Systematic Evolution of Ligands by Exponential Enrichment), an evolutionary process that involves iterative rounds of selection and amplification before sequencing and aptamer characterization.
Andrew Kinghorn   +4 more
openaire   +2 more sources

Aptamers in Immunotherapy [PDF]

open access: yesHuman Gene Therapy, 2008
Numerous nucleic acid ligands, also termed decoys or aptamer, have been developed during the past 20 years that can bind to and inhibit the activity of many proteins. The concept that nucleic acid ligands could modulate the activity of proteins emerged from basic science studies of viruses and early work in the field of gene therapy.
Claudia M, Dollins   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy